Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. (Q37013298)
Jump to navigation
Jump to search
scientific article published on March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. |
scientific article published on March 2012 |
Statements
Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies (English)
J Fowler
M Jarratt
A Moore
K Meadows
A Pollack
Y Liu
M Leoni
Brimonidine Phase II Study Group
1 March 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference